Lung Cancer – Melissa Johnson, MD, and Robert Figlin, MD, discuss clinical highlights from the 19th World Lung Conference

Lung Cancer – Melissa Johnson, MD, and Robert Figlin, MD, discuss clinical highlights from the 19th World Lung Conference

Friday October 5, 2018

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center speaks with Melissa Johnson, MD, Associate Director, Lung Cancer Research, Sarah Cannon Research Institute about targeted therapy, prevention, I-O in NSCLC, and I-O in SCLC.

Multiple Myeloma – Sagar Lonial, MD, and Robert Figlin, MD, discuss clinical highlights from ASH 2018

Wednesday December 12, 2018

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Sagar Lonial, MD, Professor and Chair, Hematology & Medical Oncology, Chief Medical Officer, Winship Cancer Institute of Emory University, discuss ALCYONE, GRIFFIN, and maintenance therapy (TOURMALINE-MM3), and other multiple myeloma clinical studies presented at the American Society of Hematology 2018 meeting

Featured Videos

Raymond Wadlow, MD, on surrogate biomarkers in the treatment of hepatocellular carcinoma

Alexander Spira, MD, PhD, FACP, on the recent approval of atezolizumab in SCLC

Melissa Johnson, MD, considers the recent data investigating atezolizumab in SCLC